Form 4 for TECH Bio-Techne
Accepted 2026-08-18 17:13:26 ET · period of report 2026-08-15 · accession 0000914190-26-000120 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-18 17:13 | 2026-08-15 | TECH | Geist William | Pres, PROTEIN SCIENCES | M - OptEx | $0.00 | +6,416 | 26.9K | +31% | $0 |
| D | 2026-08-18 17:13 | 2026-08-15 | TECH | Geist William | Pres, PROTEIN SCIENCES | F - Tax | $72.40 | -1,976 | 24.9K | -7% | -$143.1K |
| DM | 2026-08-18 17:13 | 2026-08-15 | TECH | Geist William | Pres, PROTEIN SCIENCES | M - OptEx | $0.00 | -6,416 | 6,452 | -50% | $0 |
| DM | 2026-08-18 17:13 | 2026-08-15 | TECH | Geist William | Pres, PROTEIN SCIENCES | D - Sale to Iss | $0.00 | -31.4K | 1,526 | -95% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-15 | M | A | 6,416 | $0.00 | 26,919 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-15 | F | D | 1,976 | $72.40 | 24,943 | D | — | — | |
| 3 | Derivative | Performance Restricted Stock Units | 2026-08-15 | M | D | 567 | $0.00 | 8,507 | D | — · — to — | 567 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F3) On 8/15/2026, the Board of Directors authorized discretionary vesting for 567 performance RSUs. The remainder of the performance RSUs were forfeited. (F3) On 8/15/2026, the Board of Directors authorized discretionary vesting for 567 performance RSUs. The remainder of the performance RSUs were forfeited. |
| 4 | Derivative | Performance Restricted Stock Units | 2026-08-15 | D | D | 8,507 | $0.00 | 0 | D | — · — to — | 8,507 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F3) On 8/15/2026, the Board of Directors authorized discretionary vesting for 567 performance RSUs. The remainder of the performance RSUs were forfeited. (F3) On 8/15/2026, the Board of Directors authorized discretionary vesting for 567 performance RSUs. The remainder of the performance RSUs were forfeited. |
| 5 | Derivative | Performance Stock Options (Right to Buy) | 2026-08-15 | D | D | 22,898 | $0.00 | 1,526 | D | $84.61 · — to — | 22,898 Common Stock | (F5) On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,526 performance options. The remainder of the performance options were forfeited. (F5) On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,526 performance options. The remainder of the performance options were forfeited. |
| 6 | Derivative | Restricted Stock Units | 2026-08-15 | M | D | 2,623 | $0.00 | 2,623 | D | — · — to — | 2,623 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F7) 2,623 restricted stock units vest on each of 8/15/2026 and 8/15/2027. (F7) 2,623 restricted stock units vest on each of 8/15/2026 and 8/15/2027. |
| 7 | Derivative | Restricted Stock Units | 2026-08-15 | M | D | 3,226 | $0.00 | 6,452 | D | — · — to — | 3,226 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F10) 3,226 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. (F10) 3,226 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. |